Clinical trial
FOCUS Fatigue Outcome in Copaxone USers
NCT00267319 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00267319 |
|---|---|
| Title | FOCUS Fatigue Outcome in Copaxone USers |
| Official title | Fatigue Outcomes of Copaxone Users in Relapsing-remitting Multiple Sclerosis |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Glatiramer acetate |
| Enrollment | 111 |
| Start date | Jun 1, 2003 |
| Primary completion | Oct 1, 2006 |
| First posted | Dec 20, 2005 |
| Last update posted | Dec 7, 2009 |
| Countries | Czechia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: